FabRx announces launch of M3DIMAKER
FabRx Ltd., the innovative pharmaceutical biotechnology spin-out from University College London (UCL) pioneering 3D printing of pharmaceuticals, has released the first pharmaceutical 3D printer M3DIMAKER for the manufacture of personalised medicines. FabRx is thrilled to announce that their cutting edge alternating nozzle 3D printing system, which has been tested in hospitals, pharmacies and research institutes around the world, has now been launched onto the market.
Continue reading “FabRx announces launch of M3DIMAKER, first pharmaceutical 3D printer for manufacturing personalised medicines”
FabRx starts crowdfunding campaign for personalised medicine 3D Printer
The new printer and software produces personalised medicines adapted for individual patients’ needs
FabRx is the first pharmaceutical company to work and act on the dream of personalised medicines using 3D printing technology. FabRx, in partnership with The Magic Candy Factory are working together to adapt a confectionary 3D printer to prepare medicines that are ideal for children. FabRx announces the starting of a crowdfunding campaign to raise money and create awareness about this innovative technology on Wednesday 6th December. You can find more information about the Kickstarter campaign in the following link:
The new printer allows the tailored manufacturing of medicines, including:
• precise dose medication (personalised doses)
• the combination of more than one drug (Polypill)
• a range of formulations (tablets, capsules, chewable formulations) and
• preparing these medicines on-demand in hospitals or pharmacies Continue reading “FabRx starts crowdfunding campaign for personalised medicine 3D Printer”
GE Healthcare opens first 3D Printing lab
GE Healthcare has opened its first 3D printing lab, called the Innovative Design and Advanced Manufacturing Technology Center for Europe, in Uppsala, Sweden. The center will use technologies including 3D printing and robotics to speed up the launch of new innovative products for the healthcare industry.
The center combines advanced manufacturing technology such as metal and polymer printers and collaborative robots, or “cobots”, with traditional machining equipment. A key in realizing the advantages of 3D printing is ensuring the technology is considered at the start of the innovation process with Research and Design teams working with advanced manufacturing engineers and in collaboration with customers. The new center in Uppsala will ensure additive expertise is available from the start of product design. Teams will design, test and produce 3D-printed parts for GE Healthcare products and prepare for final transfer to manufacturing. Continue reading “GE Healthcare opens first 3D Printing lab”
CloudMarketResearch Is Media Partner of 3D Medicine Printing Conference, which will take place on Feb 01, 2017 at MECC Maastricht in The Netherlands Continue reading “CloudMarketResearch Is Media Partner of 3D Medicine Printing Conference”
Tikcit is registration platform partner of 3D Medicine Printing Conference, which will take place on Feb 01, 2017 at MECC Maastricht in The Netherlands
Organising an event implies many issues, from ticketing to e-payments, from statistics to ordering supplies, from surveys to social media and many many more. Tikcit is the platform to support you. Continue reading “Tikcit is registration platform partner of 3D Medicine Printing Conference”
3D printed silk ‘micro-rockets’ could deliver medicines through your body
Sheffield engineers make major breakthrough in developing silk ‘micro-rockets’ that can be used safely in biological environments.
By using an innovative 3D inkjet printing method, researchers from Chemical and Biological Engineering at the University of Sheffield have taken the biggest step yet in producing microscopic silk swimming devices that are biodegradable and harmless to a biological system. Continue reading “3D printed silk ‘micro-rockets’ could deliver medicines through your body (Video)”
Future of 3D medicine printing: One pill shall rule them all
A team of researchers from the National University of Singapore (NUS) have found a way to make personalised medicine cheaper and easier. Imagine if you could combine the myriad of pills you need to take for your ailment in just one tablet; or if you need only to take the medication once a day and the drug will be slowly released throughout the day at different rates to treat your illness; or if doctors could easily make tablets on the spot that are tailored to each patient’s needs.
All these could become a reality with a new method of tablet fabrication designed by Assistant Professor Soh Siow Ling and PhD student Ms. Sun Yajuan from the Department of Chemical and Biomolecular Engineering at the NUS Faculty of Engineering. The novel system can make customisable pills that release drugs with any desired release profiles. Continue reading “Future of 3D medicine printing: One pill shall rule them all”
Aprecia Pharmaceuticals announced that SPRITAM® (levetiracetam) tablets, for oral suspension, is now available as an adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures.
SPRITAM is the first prescription drug product approved by the U.S. Food and Drug Administration (FDA) that is manufactured using 3D printing technology. Continue reading “First FDA-Approved 3D Printed Medicine Becomes Available”
“The regulatory perspective: benefits and limits of 3D printed drugs” – Presented by Dr. William Shang, Johnson & Johnson. 3DP technology is already up and running in many areas. The future definitely looks promising when considering the idea of 3DPs, but are the regulatory agencies ready for such technology? The presentation will reflect the regulators views and concerns about pharmaceutical development, manufacturing and control of this new technology. Potential clinical and preclinical obstacles in terms of practical use will be addressed as well.
About Dr. William Shang Continue reading ““The regulatory perspective: benefits and limits of 3D printed drugs” – Presented by Dr. William Shang, Johnson & Johnson”
Tobias D. Gantner, MD, MBA, LL. M., HealthCare Futurists GmbH, will Speak at the 3D Medicines Printing Conference on “Imprintables: A new class of products empowering patients, physicians and consumers alike.”
With the IoT, subjects that belong together finally come closer together. The medically interested public and a growing number of patients have gotten used to wearables and ubiquitous computing. Physicians, sick funds and governmental bodies are slowly adapting data usage generated from microelectronics.
The medical innovation reformation also brings the maker-scene to prostheses engineering, employing 3D printing technology. 3D printing of medicines has shown first successes and yet is still a far cry from putting pharmacy’s business models in jeopardy. Continue reading “Tobias D. Gantner, MD, MBA, LL. M., HealthCare Futurists GmbH, will Speak at the 3D Medicines Printing Conference on “Imprintables: A new class of products empowering patients, physicians and consumers alike.””